Phathom Pharmaceuticals: VOQUEZNA hits 1 million U.S. prescriptions milestone

Traders Union
All News
Companies
VOQUEZNA hits 1 million milestone

Top Stories

Editors' Picks

Crypto

Financial News

Currencies

Market Voices

Companies

Regulators News

Central Banks News

13.01.2026

Phathom Pharmaceuticals: VOQUEZNA hits 1 million U.S. prescriptions milestone — @phathompharma: VOQUEZNA hits 1 million milestone

Phathom Pharmaceuticals has announced that its medication, VOQUEZNA, has surpassed the milestone of 1 million prescriptions dispensed in the United States since its launch. This achievement marks a significant moment for the company in its efforts to address patients' needs through this treatment.

The company expressed gratitude towards healthcare providers, patients, and its internal community, referred to as the PhathomPhamily, for their roles in achieving this level of market penetration. The milestone underscores the growing acceptance and demand for VOQUEZNA, potentially influencing Phathom's strategic direction in the pharmaceutical market.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.

Did you like the article?

Editor's Picks for You

Bitcoin price prediction based on RSI: Is BTC poised for a new rally?

By Oleg Tkachenko
2 hours ago

Bitcoin price prediction based on RSI: Is BTC poised for a new rally?

Editors' Picks

Toncoin becomes Gram: Why Durov restored token's original name

By Anastasiia Chabaniuk
Yesterday

Toncoin becomes Gram: Why Durov restored token's original name

Editors' Picks

Why Tether flipping Ethereum is a pivotal moment for crypto

By Kyle Torpey
15.06.2026

Why Tether flipping Ethereum is a pivotal moment for crypto

Editors' Picks

All Editors' Top Picks

Latest Phathom News

Phathom Pharmaceuticals scheduled for 2:40 PM fireside chat at major healthcare event

By Anastasiia Chabaniuk
09.06.2026

Phathom Pharmaceuticals scheduled for 2:40 PM fireside chat at major healthcare event

Companies

Phathom Pharmaceuticals unveils commercial strategy momentum at Jefferies conference

By Igor Krasulya
08.06.2026

Phathom Pharmaceuticals unveils commercial strategy momentum at Jefferies conference

Companies

Phathom Pharmaceuticals honors Tachi Yamada legacy in GI medicine

By Mikhail Vnuchkov
05.06.2026

Phathom Pharmaceuticals honors Tachi Yamada legacy in GI medicine

Companies

All Phathom News

Oleg Tkachenko
2 hours ago

Bitcoin price prediction based on RSI: Is BTC poised for a new rally?

Anastasiia Chabaniuk
Yesterday

Toncoin becomes Gram: Why Durov restored token's original name

Kyle Torpey
15.06.2026

Why Tether flipping Ethereum is a pivotal moment for crypto

Eugene Komchuk
15.06.2026

MiCA deadline: Why crypto companies are leaving Europe

Mikhail Vnuchkov
13.06.2026

From “Holy Trinity” to WLD crash: How Arthur Hayes became a market-moving seller

Mikhail Vnuchkov
2 min ago

Michael Pettis: USSR maximized output under soft budget constraints at expense of value

Yulia Slavina
11 min ago

UK inflation holds at 2.8 percent in May as market yields fall, Mohamed A. El-Erian notes

Hlib Chabaniuk
16 min ago

66 percent of joint deposits allegedly spent on personal living costs, Nick Gillespie reveals

Hanna Syniavska
21 min ago

Willem Middelkoop: Mining bull market begins new phase

Ashutosh Sureka
21 min ago

Scott Redler: Premarket update on NVDA, TSLA, SPCX, SNDK stocks

Weekly Top Bonuses

Capitalcore

up to $2,500
deposit bonus for all clients

Your capital is at risk.

Top News

Eugene Komchuk
19 min ago

Traders Union research: 58% of crypto investors have encountered scams

Traders Union research: 58% of crypto investors have encountered scams

Parshwa Turakhiya
2 hours ago

Sam Bankman-Fried weighs token launch after prison sentence

Sam Bankman-Fried weighs token launch after prison sentence

Ivan Andriyenko
3 hours ago

U.S. futures rise before Fed rate decision

U.S. futures rise before Fed rate decision

Olga Shendetskaya
4 hours ago

Oil falls as Hormuz uncertainty keeps traders cautious

Oil falls as Hormuz uncertainty keeps traders cautious

Eugene Komchuk
4 hours ago

Binance risks losing access to EU market over MiCA license issues

Binance risks losing access to EU market over MiCA license issues

Top 5 companies for you

United States

Live News

Anton Kharitonov
Now

Bitcoin holds below $68,000 as market awaits signals from ETFs and Fed

Anton Kharitonov
Now

WTI updates local lows as returning supply and fading geopolitical risk premium weigh on prices

Mykhailo Ihnatenko
Now

Unilever balances AI ambitions and weak sales

Anton Kharitonov
Now

Natural gas remains capped below 3.10 as downside risks persist

Mykhailo Ihnatenko
Now

Ethereum awaits biggest upgrade in years as demand remains weak

© IAFT Ltd., 2010-2026 All rights to the website are owned by IAFT Ltd.,
Registration number - HE 336186

Risk disclosure:

Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit. Trading in futures and options carries substantial risk of loss and is not suitable for every investor.

That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.
Disclaimer:

Traders Union (TradersUnion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it.

Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.
Disclosure of advertisers and revenues:

All the services on the Tradersunion.com website are free for you to use. Our team spends thousands of hours per annum researching brokers and gathering information about them to help investors all over the world to choose reliable companies and to avoid fraudsters.

Indeed, the curating, sourcing, and organization of this process requires substantial financial investment by Tradersunion.com, which the website earns in the form of advertising payments. There are two types of advertising services on the website — direct advertising or partner (broker) participation programs. However, no services purchased by our partners shall affect the recommendations on our website, or our opinions, or ratings. Our ratings are based on our objective rating criteria and methodology; and the results are always equally and fairly applied to each broker. The work of our content authors and research groups does not involve any interaction with our advertisers and they do not have access to data concerning the amount of advertising purchased. For over 10 years we consider our independence, absolute openness, and objectivity as our main priority. Please follow the links to each of our affiliated broker’s websites. This will help Tradersunion.com to continue to provide our services to you for free.